132 related articles for article (PubMed ID: 38621431)
1. Plasma Concentrations of Trimethylamine-N-Oxide, Choline, and Betaine in Patients With Moderate to Advanced Chronic Kidney Disease and Their Relation to Cardiovascular and Renal Outcomes.
Obeid R; Awwad H; Heine GH; Emrich IE; Fliser D; Zawada AM; Geisel J
J Ren Nutr; 2024 Apr; ():. PubMed ID: 38621431
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
3. Plasma Concentrations of Trimethylamine-N-oxide Are Directly Associated with Dairy Food Consumption and Low-Grade Inflammation in a German Adult Population.
Rohrmann S; Linseisen J; Allenspach M; von Eckardstein A; Müller D
J Nutr; 2016 Feb; 146(2):283-9. PubMed ID: 26674761
[TBL] [Abstract][Full Text] [Related]
4. Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
Guo F; Dai Q; Zeng X; Liu Y; Tan Z; Zhang H; Ouyang D
Int Urol Nephrol; 2021 Mar; 53(3):539-551. PubMed ID: 32945995
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
[TBL] [Abstract][Full Text] [Related]
6. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
[TBL] [Abstract][Full Text] [Related]
7. Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Shea JW; Jacobs DR; Howard AG; Lulla A; Lloyd-Jones DM; Murthy VL; Shah RV; Trujillo-Gonzalez I; Gordon-Larsen P; Meyer KA
Am J Clin Nutr; 2024 Jan; 119(1):29-38. PubMed ID: 37865185
[TBL] [Abstract][Full Text] [Related]
8. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
11. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
[TBL] [Abstract][Full Text] [Related]
12. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
13. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.
Fretts AM; Hazen SL; Jensen P; Budoff M; Sitlani CM; Wang M; de Oliveira Otto MC; DiDonato JA; Lee Y; Psaty BM; Siscovick DS; Sotoodehnia N; Tang WHW; Lai H; Lemaitre RN; Mozaffarian D
JAMA Netw Open; 2022 May; 5(5):e2213242. PubMed ID: 35594043
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
[TBL] [Abstract][Full Text] [Related]
15. Whole egg consumption increases plasma choline and betaine without affecting TMAO levels or gut microbiome in overweight postmenopausal women.
Zhu C; Sawrey-Kubicek L; Bardagjy AS; Houts H; Tang X; Sacchi R; Randolph JM; Steinberg FM; Zivkovic AM
Nutr Res; 2020 Jun; 78():36-41. PubMed ID: 32464420
[TBL] [Abstract][Full Text] [Related]
16. Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year.
Kühn T; Rohrmann S; Sookthai D; Johnson T; Katzke V; Kaaks R; von Eckardstein A; Müller D
Clin Chem Lab Med; 2017 Feb; 55(2):261-268. PubMed ID: 27447240
[TBL] [Abstract][Full Text] [Related]
17. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
18. Resistant Starch Type-2 Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis Patients.
Kemp JA; Dos Santos HF; de Jesus HE; Esgalhado M; de Paiva BR; Azevedo R; Stenvinkel P; Bergman P; Lindholm B; Ribeiro-Alves M; Mafra D
J Am Nutr Assoc; 2022; 41(8):788-795. PubMed ID: 35512757
[TBL] [Abstract][Full Text] [Related]
19. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
20. Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis.
Chang D; Xu X; Yang Z; Ma T; Nie J; Dong J
Perit Dial Int; 2022 Nov; 42(6):622-630. PubMed ID: 34724845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
